In the era of precision medicine, Companion Diagnostics (CDx) have emerged as the cornerstone of targeted therapy. By identifying the specific biological characteristics of a patient, CDx solutions enable clinicians to select the most effective treatments while minimizing adverse effects. As a leading manufacturer in China, Shenzhen BioX Medical Co., Ltd. provides high-precision diagnostic tools that bridge the gap between drug development and clinical application.
SQM Facility
Expert Staff
Global Regions
Years Innovation
Our comprehensive portfolio—ranging from nucleic acid extraction systems to real-time quantitative PCR (RT-qPCR) platforms—is designed to meet the rigorous demands of global biotechnology companies and healthcare providers. By integrating automated workflows, we ensure that labs can scale their testing capabilities without compromising analytical accuracy.
Shenzhen, China, has become the global epicenter for medical device innovation. The "Shenzhen Speed" is not just about rapid assembly; it’s about a deeply integrated ecosystem of raw material suppliers, high-precision engineering firms, and top-tier logistics providers. For global enterprises, sourcing CDx solutions from China offers several distinct advantages:
From PCB design to complex optical sensor calibration, the proximity of the supply chain allows for rapid prototyping and reduced lead times.
Economies of scale enable us to offer medical-grade diagnostic platforms at a competitive price point, ensuring broader access to precision medicine.
With direct access to major international shipping hubs, we guarantee the safe and timely delivery of sensitive laboratory equipment worldwide.
Established in 2017, Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems. Headquartered in the biotechnology hub of Shenzhen, we focus on the research, development, and production of technologies that empower clinical laboratories and research institutions.
With a workforce of over 200 multidisciplinary professionals, we implement comprehensive quality control throughout the design and manufacturing phases. Our facilities are compliant with international standards, ensuring that every unit—from automated nucleic acid extractors to blood analysis systems—performs with absolute reliability.
Navigating the regulatory landscape is the biggest hurdle in the companion diagnostics industry. Whether it is FDA clearance in the United States, CE-IVDR compliance in Europe, or NMPA registration in China, BioX Medical provides the necessary documentation and validation data to support our clients' regulatory filings.
As we look toward 2030, several trends are reshaping the CDx landscape:
For international distributors and diagnostic companies, choosing a partner like BioX Medical involves more than just buying hardware. We offer flexible OEM and ODM services to ensure the technology integrates perfectly into your existing ecosystem. Our support includes:
Stringent internal audits and ISO-certified manufacturing processes to guarantee batch-to-batch consistency.
Dedicated engineering teams to assist with installation, calibration, and after-sales maintenance across global markets.
Capacity to scale production rapidly to meet sudden market surges or large-scale government procurement tenders.
Our products are manufactured under ISO 13485 standards. Depending on the specific model, we provide CE, RoHS, and NMPA certifications to facilitate international market entry.
Yes, through our ODM service, we can customize PCR thermal cycling parameters, optical detection channels, and software interfaces to match your specific biomarker assays.
We use high-precision components, including high-stability thermal modules and sensitive fluorescence detection systems, all validated against clinical gold standards during the R&D phase.
Standard products typically ship within 2-4 weeks. For large OEM orders or customized solutions, lead times are discussed based on the project scope, usually ranging from 8-12 weeks.
Absolutely. Our modern diagnostic platforms support LIS/HIS integration via standard protocols (HL7/ASTM) for seamless data management and patient reporting.
BioX Medical
